We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.97%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$83.2B
AUM Growth
+$1.08B
(+1.3%)
Cap. Flow
-$819M
Cap. Flow
% of AUM
-0.99%
Top 10 Holdings %
Top 10 Hldgs %
34.54%
Holding
3,151
New
709
Increased
920
Reduced
837
Closed
626
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.06B |
| 2 |
UnitedHealth
UNH
|
+$935M |
| 3 |
Uber
UBER
|
+$426M |
| 4 |
Boeing
BA
|
+$312M |
| 5 |
Salesforce
CRM
|
+$309M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.09B |
| 2 |
Meta Platforms (Facebook)
META
|
+$644M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$628M |
| 4 |
GE Vernova
GEV
|
+$439M |
| 5 |
Eli Lilly
LLY
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.14% |
| 2 | Consumer Discretionary | 14.92% |
| 3 | Healthcare | 12.54% |
| 4 | Financials | 8.46% |
| 5 | Industrials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBL
1851
CBL Properties
CBL
$1.86B
| $727K | ﹤0.01% |
24,712
+8,384
| +51% | +$238K |
|
1852
Solid Biosciences
SLDB
$785M
| $726K | ﹤0.01% |
181,501
-5,869
| -3% | -$32.2K |
|
1853
Verra Mobility
VRRM
$635M
| $724K | ﹤0.01% |
29,955
-366,612
| -92% | -$9.08M |
|
1854
Procept Biorobotics
PRCT
$1.03B
| $719K | ﹤0.01% |
8,928
-6,224
| -41% | -$532K |
|
1855
KRONOS Worldwide
KRO
$712M
| $715K | ﹤0.01% |
73,357
-5,466
| -7% | -$61.4K |
|
1856
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $714K | ﹤0.01% |
7,923
+2,600
| +49% | +$252K |
|
1857
Amkor Technology
AMKR
$11.3B
| $712K | ﹤0.01% |
+27,717
| New | +$762K |
|
1858
Natural Gas Services Group
NGS
$460M
| $712K | ﹤0.01% |
26,550
-51,667
| -66% | -$1.21M |
|
1859
TriNet
TNET
$3.14B
| $711K | ﹤0.01% |
7,834
-3,518
| -31% | -$325K |
|
1860
Pliant Therapeutics
PLRX
$66.3M
| $710K | ﹤0.01% |
+53,880
| New | +$736K |
|
1861
Contango Silver & Gold Inc
CTGO
$529M
| $706K | ﹤0.01% |
70,438
+57,976
| +465% | +$985K |
|
|
ONIT
1862
Onity Group
ONIT
$341M
| $703K | ﹤0.01% |
+22,889
| New | +$708K |
|
1863
Korro Bio
KRRO
$151M
| $703K | ﹤0.01% |
+18,461
| New | +$949K |
|
1864
Compass Minerals
CMP
$1.25B
| $701K | ﹤0.01% |
62,321
-16,838
| -21% | -$220K |
|
1865
Amylyx Pharmaceuticals
AMLX
$2.17B
| $698K | ﹤0.01% |
184,678
-99,308
| -35% | -$467K |
|
1866
Brown-Forman Class A
BF.A
$13.4B
| $697K | ﹤0.01% |
+18,505
| New | +$800K |
|
1867
Wabash National
WNC
$541M
| $695K | ﹤0.01% |
+40,600
| New | +$753K |
|
1868
Simpson Manufacturing
SSD
$8.16B
| $694K | ﹤0.01% |
4,187
-1,974
| -32% | -$362K |
|
|
CUK
1869
DELISTED
Carnival PLC
CUK
| $693K | ﹤0.01% |
30,800
-8,400
| -21% | -$178K |
|
1870
Evercore
EVR
$13.2B
| $693K | ﹤0.01% |
+2,500
| New | +$708K |
|
1871
Mistras Group
MG
$490M
| $689K | ﹤0.01% |
76,093
+7,308
| +11% | +$72K |
|
|
TPH
1872
DELISTED
Tri Pointe Homes
TPH
| $688K | ﹤0.01% |
18,975
-798
| -4% | -$33.3K |
|
|
FOLD
1873
DELISTED
Amicus Therapeutics
FOLD
| $687K | ﹤0.01% |
72,968
+52,368
| +254% | +$544K |
|
1874
Rocket Companies
RKT
$39.6B
| $687K | ﹤0.01% |
61,009
-244,922
| -80% | -$3.65M |
|
|
PPLI
1875
People Inc
PPLI
$3.13B
| $686K | ﹤0.01% |
19,382
-14,754
| -43% | -$591K |
|
Similar funds
Marshall Wace's Q4 2024 Portfolio in Review
As of Q4 2024, Marshall Wace held 3,151 positions worth $83.2B, up 1.3% from $82.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace's Q4 2024 filing shows 709 new, 920 increased, 837 reduced and 626 closed positions. Its largest new stake was Boeing: 1,988,038 shares worth $352M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Marshall Wace's largest Q4 2024 buy was Boeing: 1,988,038 shares worth $352M.
- Marshall Wace added most to Apple in Q4 2024, an estimated $1.06B increase.
- Marshall Wace's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.09B.
- Marshall Wace fully exited GE Vernova in Q4 2024, selling an estimated $439M.
- Marshall Wace's ten largest holdings make up 35% of its $83.2B portfolio in Q4 2024.
- Marshall Wace opened 709 new positions and closed 626 in Q4 2024.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $83.2B.
Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.